首页 > 市场调查报告书 > 医疗设备

病患监测呼吸器

市场调查报告书

商品编码

1304528

全球呼吸监测设备市场 - 2023-2030

Global Respiratory Monitoring Devices Market - 2023-2030

出版日期: 2023年07月07日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球呼吸监测设备市场规模在2022年达到46亿美元，预计到2030年将实现利润丰厚的增长，达到93亿美元。预计在2023-2030年期间，全球呼吸监测设备市场将呈现9.3%的复合年增长率。

呼吸监测设备评估呼吸道的正常运行和氧气输送。目前正在开发几种呼吸测试，以评估肺部在交换呼吸气体和发现呼吸道堵塞方面的功效。呼吸监测设备的销售用于扩大呼吸监测设备市场。

呼吸监测设备跟踪与呼吸有关的参数，有助于诊断呼吸系统疾病。日益严重的空气污染、呼吸系统疾病病例、老年人口和市场发展促进了全球呼吸监测设备市场的发展。

市场动态

老年人口增加

在预测期内，老年人口的增加是推动市场增长的重要因素之一。老年人口的增加导致呼吸监测设备的增加，因为在这个年龄段人的免疫系统变得脆弱，呼吸监测设备的使用是必不可少的，这确实有助于市场在预测期内的增长。

例如，根据NCBI发表的文章，吸烟者、酗酒者、使用多种药物和合并其他疾病是影响感染呼吸系统疾病的老年人治疗效果的因素，这些老年人确实需要呼吸监测设备，这有助于未来市场的增长。

医疗保健支出增加

发达国家和发展中国家医疗保健支出的增长推动了呼吸护理设备市场的发展。这是由于这些国家的政府在提高医疗设施质量方面的支出。此外，新兴国家人均医疗保健支出的增长等因素（主要是由于政府倡议的增加）将有可能提高治疗的可负担性和可及性，从而推动市场扩张。

例如，根据国际呼吸学会论坛的数据，哮喘和慢性阻塞性肺疾病每年导致约48.9万人死亡，即每天有1300多人死亡，影响全球2亿多人，其中6500万人患有中度或重度气道疾病。因此，慢性阻塞性肺病和哮喘等呼吸系统疾病发病率的上升推动了市场的发展。

缺乏对呼吸监测设备的认识

市场增长的制约因素之一是缺乏对呼吸监测设备的认识。缺乏信息和设备的使用将导致市场增长放缓。

许多情况都会影响市场，包括个人不了解这些设备，不能识别呼吸系统疾病的早期症状和体征，或不需要监测呼吸系统健康状况。这就造成了就医的延误，从而导致诊断和治疗的延迟。

COVID-19影响分析

随着全球COVID-19病例的增加，对包括脉搏血氧仪、呼吸机和肺活量计在内的呼吸监测设备的需求急剧上升。这些设备对于监测血氧饱和度水平、肺功能以及为急性呼吸窘迫患者提供呼吸辅助至关重要。供应链问题也是一个因素，呼吸监测设备需求的增长给全球供应链带来了压力。

俄乌战争影响分析

据估计，俄乌冲突对全球呼吸监测设备市场的影响不大，因为该地区的主要市场参与者较少。然而，原材料进出口的影响预计在预测期内对全球呼吸监测设备市场增长的影响不大。

Market Overview

The Global Respiratory Monitoring Devices Market reached US$ 4.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 9.3 billion by 2030. The global respiratory monitoring devices market is expected to exhibit a CAGR of 9.3% during the forecast period 2023-2030.

A Respiratory Monitoring Device Evaluates the airways' regular operation and oxygen delivery. Several respiratory tests are being developed to evaluate the efficacy of the lungs in exchanging breathing gases and finding respiratory tract blockages. Sales of respiratory monitoring devices are used to augment the respiratory monitoring device market.

Respiratory Monitoring Devices track parameters related to breathing, which help diagnose respiratory illnesses. The growing air pollution, cases of respiratory disorders, geriatric population, and market developments promote the global respiratory monitoring devices market.

Market Dynamics

Rise in Geriatric Population

The rise in the geriatric population is one of the significant drivers that drive the market growth in the forecast period. The rise in the population of older people led to increasing the respiratory monitoring devices since the immune system of a person gets weak at this age where the requirement of respiratory monitoring devices is essential to use, which indeed helps the market to grow during the forecast period.

For instance, according to the article published in NCBI, being a smoker, an alcoholic, polypharmacy, and the presence of additional co-morbidities were factors that affected the treatment results of older adults infected with respiratory diseases which indeed needed respiratory monitoring devices that helps the market to grow in future.

Increasing Healthcare Expenditure

The respiratory care devices market is driven by rising healthcare expenditures in developed and developing nations. This is due to those nations' governments are spending in enhancing the quality of healthcare facilities. Furthermore, factors such as rising healthcare spending per capita in emerging nations, mainly due to increased government initiatives, will likely boost treatment affordability and accessibility, aiding market expansion.

For instance, according to the Forum of International Respiratory Societies, Asthma and COPD cause around 489,000 fatalities per year, or more than 1300 deaths per day, and impact more than 200 million people worldwide, with 65 million having moderate or severe airway disease. As a result, the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease and asthma is propelling the market forward.

Lack of Awareness of Respiratory Monitoring Devices

One of the restraints to market growth is a lack of awareness of respiratory monitoring devices. The lack of information and utilization of the devices will lead to a reduction in market growth.

Many conditions affect the market, including individuals unaware of these devices and failing to recognize the early signs and symptoms of respiratory disorders or the need to monitor their respiratory health. This causes delays in seeking medical attention, leading to delayed diagnosis and treatment.

COVID-19 Impact Analysis

With the growth of COVID-19 cases worldwide, the need for respiratory monitoring devices, including pulse oximeters, ventilators, and spirometers, has skyrocketed. These devices are critical for monitoring oxygen saturation levels, lung function, and respiratory assistance to patients suffering from acute respiratory distress. Supply chain issues have also been a factor, with growing demand for respiratory monitoring equipment putting strain on the worldwide supply chain.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global respiratory monitoring devices market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global respiratory monitoring devices market growth over the forecast period.

Segment Analysis

The Global Respiratory Monitoring Devices Market is segmented based on product, end user and region.

The Peak Flow Meters Product Segment Accounted for Approximately 24.9% of the Respiratory Monitoring Devices Market Share

The peak flow meter devices are used to measure the rate of breathing. Peak flow meters that are lightweight, simple to handle and transport, and remotely accessible are in high demand. For instance, On April 18 2023, Tenovi has introduced a cellular FDA-cleared remote peak flow meter (PFM) for advanced remote physiological monitoring of asthmatic patients.

When combined with Tenovi's cellular gateway, the device allows patients with asthma to transmit peak expiratory flow rate (PEF) and 1-second forced expiratory volume (fev1) readings instantly to clinicians. Asthma is a chronic respiratory condition that affects millions of people worldwide, and effective monitoring of asthmatic symptoms is essential for proper management.

Geographical Analysis

North America Accounted for Approximately 39.5% of the Market Share Owing to the Strong Presence of Major Players.

North America is estimated to hold about 39.5% of the total market share throughout the forecast period. The dominating market, such as the United States, is distinguished by increased healthcare expenditures, robust healthcare infrastructure, and enhanced access to healthcare services.

The average per capita healthcare spending in the United States was $40,624 in 2022. Furthermore, rising public awareness of the many sophisticated respiratory monitoring equipment has aided North American respiratory monitoring devices' growth.

Competitive Landscape

The major global players in respiratory monitoring devices include: GE Healthcare, Smith & Nephew, Vyaire (CareFusion Corporation), Masimo Corporation, Medtronic, MGC Diagnostics Corporation, COSMEDN, Nihon Kohden Corporation, Philips Healthcare, and Novelda AS, among others.

Why Purchase the Report?

To visualize the Global Respiratory Monitoring Devices Market segmentation based on product, end user and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of respiratory monitoring devices market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The Global Respiratory Monitoring Devices Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Respiratory Diseases
  - 4.1.1.2. Rise in Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Longer Duration of Approval Process
- 4.1.3. Opportunity
  - 4.1.3.1. Investment by key players in emerging markets
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Spirometer *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Peak Flow Meters
7.4. Sleep Test Devices
7.5. Gas Analyzers
7.6. Pulse Oximeters
7.7. Capnography
7.8. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers
8.4. Homecare
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. The U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. The U.K.
  - 9.3.5.3. France
  - 9.3.5.4. Spain
  - 9.3.5.5. Italy
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan

Australia

9.5.5.4. Rest of Asia-Pacific

9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. GE Healthcare *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Smith & Nephew
11.3. Vyaire (Carefusion Corporation)
11.4. Masimo Corporation
11.5. Medtronic plc
11.6. MGC Diagnostics Corporation
11.7. COSMED
11.8. Nihon Kohden Corporation
11.9. Philips Healthcare
11.10. Novelda AS

LIST NOT EXHAUSTIVE